Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial.
Por:
Romero, A, Molina-Vila, M, Jantus-Lewintre, E, Insa, A, Cruz, P, Collazo, A, Altozano, J, Juan-Vidal, O, Diz, P, Cobo, M, Hernandez, B, Vazquez-Estevez, S, Benitez, G, Guirado, M, Rodriguez-Festa, A, Calabuig-Farinas, S, Rosell, R, Camps, C, Royuela, A and Provencio-Pulla, M
Publicada:
20 may 2020
Resumen:
Filiaciones:
Hosp Univ Puerta Hierro Majadahonda, Liquid Biopsy Lab, Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid, Spain.
Quiron Dexeus Univ Hosp, Lab Cellular & Mol Biol, Pangaea Oncol, Barcelona, Spain.
Univ Politecn Valencia, Dept Biotecnol, Lab Oncol Mol, FIHGUV,CIBERONC, Valencia, Spain.
Hosp Clin Univ Valencia, Valencia, Spain.
La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain.
Comprehens Canc Ctr Clara Campal CIOCC, Madrid, Spain.
Hosp Virgen Llrios, Valencia, Spain.
Hosp Univ & Politecn La Fe, Valencia, Spain.
Univ Hlth Care Complex Leon, Leon, Spain.
Hosp Univ Reg & Virgen Victoria Malaga, UGC Oncol Interctr, Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
Complejo Hosp Navarra, Med Oncol, Pamplona, Spain.
Lucus Augusti Univ Hosp, Lugo, Spain.
Complejo Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, CA, Spain.
Hosp Gen Elche, Clin Oncol Dept, Alicante, Spain.
Catalan Inst Oncol, Barcelona, Spain.
Gen Univ Hosp Valencia, Med Oncol Dept, Valencia, Spain.
Univ Valencia CIBERONC, Dept Med, Valencia, Spain.
Hosp Univ Puerta Hierro Majadahonda, Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid, Spain.
Univ Hosp Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain.
|